Logo
x

Search

Subscribe Now

Development Program

Takeda to Advance FIN-524 Development Program in Ulcerative Colitis

Takeda to Advance FIN-524 Development Program in Ulcerative Colitis

  • August 11, 2021
Xbrane to Initiate New Biosimilar Development Program Annually

Xbrane to Initiate New Biosimilar Development Program Annually

  • May 17, 2021
Revance and Mylan to Advance Development Program for a Proposed Biosimilar to BOTOX

Revance and Mylan to Advance Development Program for a Proposed Biosimilar to BOTOX

  • June 2, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.